Please login to the form below

Not currently logged in
Email:
Password:

Esteve appoints Albert Esteve as chairman of the board of directors

He succeeds Joan Esteve, who continues as chairman of the general shareholders meeting

Spanish pharmaceutical group Esteve has appointed Albert Esteve as its chairman of the board of directors to replace Joan Esteve, who will continue serving the group as chairman of the general shareholders meeting.

Albert Esteve joined the group as an assistant to general management and was appointed member of the group’s executive committee and has been chief executive officer since 2011.

Additionally, Staffan Schuberg will join as chief executive officer, effective January 2018, following more than 20 years’ experience from pharmaceutical companies such as Lundbeck, where he held the position of executive vice president and chief commercial officer.

Esteve said: “This is a new challenge that I am facing with tremendous enthusiasm.

“Regarding the CEO appointment, we feel fortunate and are much honoured to welcome Staffan Schuberg as the new executive leader of the group.”

3rd November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics